These results reinforce the theory that NAT10‐dependent ac4C modification is crucial for bladder cancer progression, supplying a comprehensive understanding of the elaborate regulatory mechanism of the epitranscriptome in BLCA. The gene discussed is NAT10; the disease is bladder transitional cell carcinoma.